$ENSC
Ensysce Biosciences, Inc.

2022 Q1 Form 10-Q Financial Statement

#000149315222013083 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $603.1K $250.6K
YoY Change 140.68%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.266M $490.5K
YoY Change 361.97%
% of Gross Profit
Research & Development $3.140M $324.4K
YoY Change 868.03%
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $5.406M $814.9K
YoY Change 563.42% -10.96%
Operating Profit -$4.803M
YoY Change
Interest Expense -$15.02K
YoY Change
% of Operating Profit
Other Income/Expense, Net $5.570M
YoY Change
Pretax Income -$950.9K -$951.7K
YoY Change -0.08% -150.97%
Income Tax
% Of Pretax Income
Net Earnings -$951.1K -$947.7K
YoY Change 0.36% -152.87%
Net Earnings / Revenue -157.7% -378.21%
Basic Earnings Per Share -$14.66
Diluted Earnings Per Share -$34.86K -$59.24K
COMMON SHARES
Basic Shares Outstanding 113.7K shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.441M $18.03K
YoY Change 46716.14% -89.26%
Cash & Equivalents $8.441M
Short-Term Investments
Other Short-Term Assets $2.409M $190.4K
YoY Change 1165.15% 349.27%
Inventory
Prepaid Expenses
Receivables $808.6K
Other Receivables $0.00
Total Short-Term Assets $11.66M $228.2K
YoY Change 5008.63% -16.79%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.69M
YoY Change
Other Assets $713.1K $61.28K
YoY Change 1063.66% -99.9%
Total Long-Term Assets $713.1K $12.75M
YoY Change -94.41% -79.21%
TOTAL ASSETS
Total Short-Term Assets $11.66M $228.2K
Total Long-Term Assets $713.1K $12.75M
Total Assets $12.37M $12.98M
YoY Change -4.69% -78.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $959.6K $319.2K
YoY Change 200.65% -90.87%
Accrued Expenses $1.769M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.073M
YoY Change
Total Short-Term Liabilities $8.802M $319.2K
YoY Change 2657.66% -90.87%
LONG-TERM LIABILITIES
Long-Term Debt $1.587M $460.0K
YoY Change 244.98% -70.63%
Other Long-Term Liabilities $871.4K $10.31M
YoY Change -91.55% -78.07%
Total Long-Term Liabilities $2.458M $10.77M
YoY Change -77.17% -77.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.802M $319.2K
Total Long-Term Liabilities $2.458M $10.77M
Total Liabilities $10.98M $11.09M
YoY Change -0.96% -78.7%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.391M $1.894M
YoY Change
Total Liabilities & Shareholders Equity $12.37M $12.98M
YoY Change -4.69% -78.93%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$951.1K -$947.7K
YoY Change 0.36% -152.87%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$3.437M -$266.2K
YoY Change 1191.28% 13.56%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $4.500K -$62.50K
YoY Change -107.2% -100.05%
Cash From Investing Activities $4.500K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -391.3K 297.5K
YoY Change -231.52% -100.22%
NET CHANGE
Cash From Operating Activities -3.437M -266.2K
Cash From Investing Activities 4.500K
Cash From Financing Activities -391.3K 297.5K
Net Change In Cash -3.824M $0.00
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$3.437M -$266.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 ENSC Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
USD
CY2021Q1 ENSC Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
USD
CY2021Q1 ENSC Change In Fair Value Of Liability Classified Warrants
ChangeInFairValueOfLiabilityClassifiedWarrants
USD
CY2021Q1 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
CY2021Q1 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
USD
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
USD
CY2022Q1 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount1
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
USD
CY2022Q1 us-gaap Depreciation
Depreciation
USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
USD
CY2022Q1 us-gaap Accretion Expense
AccretionExpense
USD
CY2022Q1 ENSC Change In Fair Value Of Embedded Derivative
ChangeInFairValueOfEmbeddedDerivative
USD
CY2021Q1 ENSC Change In Fair Value Of Liability Classified Warrants
ChangeInFairValueOfLiabilityClassifiedWarrants
USD
CY2021Q1 ENSC Change In Fair Value Of Convertible Debt
ChangeInFairValueOfConvertibleDebt
USD
CY2021Q1 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
USD
CY2021Q1 ENSC Increase Decrease In Unbilled Receivable
IncreaseDecreaseInUnbilledReceivable
USD
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2022Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
USD
CY2022Q1 ENSC Proceeds From Related Party Debt One
ProceedsFromRelatedPartyDebtOne
USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
CY2021Q1 ENSC Repayment Insurance Premiums
RepaymentInsurancePremiums
USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2022Q1 us-gaap Notes Issued1
NotesIssued1
USD
CY2022Q1 ENSC Deferred Transaction Costs In Accounts Payable
DeferredTransactionCostsInAccountsPayable
USD
CY2022Q1 ENSC Deferred Transaction Costs In Accrued Expenses And Other Liabilities
DeferredTransactionCostsInAccruedExpensesAndOtherLiabilities
USD
CY2021Q1 ENSC Conversions Of Convertible Notes Into Common Stock
ConversionsOfConvertibleNotesIntoCommonStock
USD
CY2021Q1 ENSC Deemed Dividend Related To Warrants Down Round Provision
DeemedDividendRelatedToWarrantsDownRoundProvision
USD
CY2022Q1 us-gaap Depreciation
Depreciation
USD
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2022Q1 ENSC Consultant Stock Compensation Expenses
ConsultantStockCompensationExpenses
USD
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
USD
CY2021Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P3Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
USD

Files In Submission

Name View Source Status
0001493152-22-013083-index-headers.html Edgar Link pending
0001493152-22-013083-index.html Edgar Link pending
0001493152-22-013083.txt Edgar Link pending
0001493152-22-013083-xbrl.zip Edgar Link pending
ensc-20220331.xsd Edgar Link pending
ensc-20220331_cal.xml Edgar Link unprocessable
ensc-20220331_def.xml Edgar Link unprocessable
ensc-20220331_lab.xml Edgar Link unprocessable
ensc-20220331_pre.xml Edgar Link unprocessable
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending